Acquisition by Raymond Woosley of 6000 shares of ARCA Biopharma subject to Rule 16b-3

About 67% of ABIO Old's investor base is looking to short. The analysis of current outlook of investing in ABIO Old suggests that many traders are alarmed regarding ABIO Old's prospects. ABIO Old's investing sentiment overview a quick insight into current market opportunities from investing in ABIO Old. Many technical investors use ABIO Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Arca Biopharma Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
ARCA insider trading alert for grant of stock option right to buy by Raymond Woosley, the corporate stakeholder, on 31st of January 2024. This event was filed by Arca Biopharma Inc with SEC on 2024-01-31. Statement of changes in beneficial ownership - SEC Form 4

ABIO Old Fundamental Analysis

We analyze ABIO Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIO Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIO Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

ABIO Old is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

ABIO Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABIO Old stock to make a market-neutral strategy. Peer analysis of ABIO Old could also be used in its relative valuation, which is a method of valuing ABIO Old by comparing valuation metrics with similar companies.

Peers

ABIO Old Related Equities

TILInstil Bio   22.36   
0%
73.0%
FBRXForte Biosciences   8.78   
0%
28.0%
NXTCNextCure   7.50   
0%
24.0%
ADAGAdagene   5.00   
0%
16.0%
TPSTTempest Therapeutics   4.55   
0%
14.0%
RZLTRezolute   3.74   
0%
12.0%
CTMXCytomX Therapeutics   3.57   
0%
11.0%
KTTAPasithea Therapeutics   2.89   
0%
9.0%
AVTEAerovate Therapeutics   1.19   
0%
3.0%
ANTXAN2 Therapeutics   0.79   
2.0%
0%
ACRVAcrivon Therapeutics,   0.88   
2.0%
0%
INDPIndaptus Therapeutics   2.11   
6.0%
0%
SPROSpero Therapeutics   3.33   
10.0%
0%
RNXTRenovoRx   3.90   
12.0%
0%
QNRXQuoin Pharmaceuticals   30.51   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in ABIO Stock

If you are still planning to invest in ABIO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIO Old's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets